newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies Announces Key Leadership Changes

ImmunoPrecise Antibodies (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce key leadership updates, including the appointment of Kamil Isaev to its